Scientists appear to have discovered a way to produce a true structure of the rare but naturally-occurring anti-HIV compound Lancilactone C from start to finish. The domino-like reaction enables the ...

Antiretroviral (ARV) therapy suppresses HIV, but viral replication rebounds once treatment is discontinued. The redistribution of lipids in the plasma membrane to form microdomains is crucial for ...

The FINANCIAL — Bristol-Myers Squibb Company (NYSE:BMY) on February 26 announced data supporting the clinical development of BMS-955176, an investigational component designed to prevent the maturation ...

During the last 20 years, a myriad of cellular proteins with various functions have been identified as capable of hindering different steps in the HIV life cycle. This effect is particularly strong ...

HIV-1 reverse transcriptase inhibitors have long been central to antiretroviral therapy, effectively impeding the enzyme responsible for converting viral RNA into DNA – a pivotal step in HIV ...

Replication of HIV-1 and simian immunodeficiency virus (SIVmac) is restricted in some cell lines but the exact intracellular mechanisms that block the virus replication are unknown. Two papers in ...

GSK’s weighty HIV pipeline just got slightly lighter as the British Big Pharma decided not to progress a once-promising candidate into late-stage trials. The asset in question, dubbed GSK3640254, was ...

Since HIV’s discovery in the 1980s, scientists have come a long way in understanding the different steps required for its assembly and maturation. Researchers knew, for instance, that HIV wraps its ...

There is currently no cure for HIV, but medications can help people with the disease manage their symptoms. HIV can still develop into AIDS years after infection, however, even with disease management ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...

HIV-1 reverse transcriptase inhibitors remain a cornerstone of antiretroviral therapy, targeting the enzyme responsible for converting viral RNA into DNA. This class of drugs, particularly nucleoside ...